Mathematical methods for diagnosing breast cancer

May 15, 2018

The team of researchers at Kaunas University of Technology, Lithuania are developing mathematical methods which could help diagnose breast cancer. Applying deep learning method, the researchers are aiming to "teach" computer to recognise malignant lesions, which would allow at least partially automatize and enhance the accuracy of diagnosing breast cancer.

In 2014, around 93.5 thousand people died from breast cancer in the EU, the vast majority (92.5 thousand) of them were women. Among women, breast cancer accounted for 3.7 % of all deaths. According to the World Health Organisation, more than 1 million new breast cancer cases are being diagnosed every year. The international community of medical professionals is warning that the incidence of oncological diseases is rising; in the last 15 years in Lithuania the cancer rate increased by 75%.

For better treatment and prognosis of cancer patients, early diagnosis is the key.

"Often in cancer diagnosis oncologists rely on visual information - the image of the tissue in question is being analysed in order to determine the nature of the lesions. This process is time consuming and the probability of mistake is not eliminated, which, in the case of cancer can be fatal. By developing mathematical methods for cancer diagnosis we aim to at least partially automatize the diagnosing procedure and to minimize the occurrence of mistakes", says Dr Tomas Iešmantas, postdoctoral researcher at Kaunas University of Technology (KTU).

For diagnosing breast cancer, he has adapted capsule neural network method introduced by the British researcher Geoffrey Hinton, one of the founding fathers of deep learning (machine learning method).

Dr Iešmantas, together with his postdoctoral research supervisor Professor Robertas Alzbutas, have analysed 100 microscope images of breast tissue provided by the University of Porto, Portugal. There were 4 types of images in the sample: those of non-cancerous tissue, of non-malignant tumour tissue, of non-invasive and invasive carcinomas. The aim of the investigation was to design a mathematical method for classifying the images into the 4 types mentioned.

"The early results are very promising - we have achieved 85% accuracy rate", says KTU researcher.

He will introduce the results of the research in the 15th International Conference on Image Analysis and Recognition in Portugal. According to Dr Iešmantas, although the ways of application of mathematical methods in medicine have expanded in recent years, and computers are being taught to diagnose lesions in lungs, to recognise metastasis in lymph nodes, and to localise brain tumours, it is not very likely that cancer diagnosing process will become fully automatized in the near future.

"The research is not only conducted on theoretical level, there are some cases where these methods have already been applied in clinical practice. Even though digitalisation will not replace human judgement, I believe that automatized computer diagnosis will become more common with time and will help to more accurately identify and diagnose certain types of cancer", says Dr Iešmantas.
-end-


Kaunas University of Technology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.